Market Research Blog – Page 993 – New Product Development

Global Digital Mobile X-Ray Devices Market Poised for Strong Growth, Set to Reach USD 7,272.7 Million by 2033

The global digital mobile X-ray devices market is expected to experience significant growth over the next decade. Valued at USD 3,873.7 million in 2023, the market is projected to expand at a 6.5% annual growth rate (CAGR), reaching a remarkable USD 7,272.7 million by 2033.

This growth is being driven by several key factors, including the increasing prevalence of chronic diseases and a growing aging population globally. As the demand for advanced healthcare solutions rises, digital mobile X-ray devices are becoming an indispensable tool for early and accurate diagnosis.

Market Trends and Key Drivers:

Rising Chronic Disease Incidences: The increasing frequency of chronic illnesses such as cardiovascular disease, diabetes, and respiratory conditions is boosting the demand for diagnostic imaging solutions, including mobile X-ray devices.
Advances in Diagnostic Technology: The introduction of sophisticated diagnostic technologies is enabling faster, clearer, and more accurate imaging. This has become a key factor fueling the market’s expansion.
Increasing Awareness for Early Diagnosis: Patients are more informed about the importance of early detection of chronic conditions, which is leading to higher demand for diagnostic services like mobile X-rays.
Growth of Mobile X-Ray Rental Services: In recent years, organizations offering digital mobile X-ray rental services have emerged, making advanced diagnostic solutions more accessible to hospitals and clinics. This trend is further supported by growing collaborations between healthcare providers and rental service companies, driving new equipment installations.
Technological Benefits of Computed Radiography (CR): Computed radiography offers considerable advantages over traditional systems, including the elimination of consumable costs and a significant reduction in image processing time, making it a preferred choice in many healthcare settings.

Industry Outlook

With the continuous innovation and technological advancements in diagnostic imaging, the digital mobile X-ray devices market is expected to remain at the forefront of healthcare transformation. Hospitals, clinics, and diagnostic centers are increasingly adopting these mobile solutions to offer more flexible and efficient patient care, particularly in remote or underserved areas.

Key Takeaways from the Digital Mobile X-Ray Devices Market Study:

The United States leads in sales of digital mobile X-ray devices, accounting for nearly 27.9% of global revenue. North America, including Canada, held a 31.1% global market share in 2022.
Germany was the dominant market in Europe, contributing approximately 7.1% to global sales in 2022.
In Asia, China is the leading market for digital X-ray device manufacturers, with a projected growth rate of 8.1% CAGR through 2033.
The computed radiography (CR) technology segment led the market, accounting for 52.6% of global revenue share in 2022.
Mobile devices currently lead the market, representing about 91.1% of total sales in 2022.
Sales of X-ray devices for installation in hospitals and medical institutes accounted for nearly 68.7% of total revenue in 2022.

Get the Latest on Digital Mobile X-Ray Devices: Our Full Report Highlights Key Trends and Insights!

Competitive Landscape:

The market is characterized by significant consolidation and competitive activity. Major players are focusing on product development and technological enhancements to stay ahead. Recent developments include:

Agfa HealthCare introduced SmartXR for X-ray AI in December 2020, aiming to enhance digital radiography in field hospitals.
Canon Medical Systems launched the OMNERA 500A Digital Radiography system in the United States in December 2020, featuring intelligent auto-positioning capabilities.
Samsung unveiled the GM85 Fit in April 2022, a new configuration of its premium digital radiography instrument, designed for efficient patient care and FDA-approved.

Key Players in the Digital Mobile X-Ray Devices Market:

Canon Inc.
Carestream Health
General Electric
Siemens Healthcare
Koninklijke Philips N.V.
FUJIFILM Corporation
Shimadzu Corporation
Ziehm Imaging GmbH
MinXray, Inc.

Market Segmentation:

By Product: Mobile Devices, Handheld Devices
By Technology: Computed Radiography, Direct Radiography
By Application: Orthopedic Imaging, Chest Imaging, Dental Imaging, Other Applications
By End User: Hospitals, Radiology Centers, Outpatient Clinics, Other End Users
By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Companion Animal Vaccines Market to Reach USD 6.7 Billion by 2033, Driven by Rising Pet Humanization and Awareness of Pet Insurance

Future Market Insights, Inc. has forecasted robust growth in the global companion animal vaccines market, with a projected compound annual growth rate (CAGR) of 6.8% between 2023 and 2033. The market, currently valued at USD 3.4 billion in 2023, is expected to more than double, reaching an estimated USD 6.7 billion by 2033.

Several key factors are fueling this growth, including:

Humanization of Pets: As pets are increasingly viewed as family members, owners are prioritizing their health and wellness, driving demand for advanced vaccines.
Growing Awareness of Pet Insurance: With more pet owners opting for insurance, preventive healthcare, including vaccinations, has become a significant focus, ensuring pets lead longer, healthier lives.
Rising Cases of Animal Diseases: An increase in the number of diseases affecting companion animals has heightened the need for effective vaccines, further propelling the market’s growth.

As companion animals play a growing role in households across the globe, the demand for vaccinations to prevent diseases is expected to remain strong, supporting the sustained expansion of the market in the coming decade.

The passage outlines two main restraining factors for the companion animal vaccines market:

Shift in Sales Channels:

The Fairness to Pet Owners Act allows pet owners to purchase vaccines from retailers and pharmacies, bypassing veterinarians.
This reduces the market share traditionally held by veterinarians and forces vaccine companies to adapt their sales strategies.
The shift might also affect profit margins due to changes in distribution channels and consolidation of veterinary clinics.

Knowledge Gaps in Disease Epidemiology:

Lack of understanding about the prevalence and spread of veterinary diseases, particularly in endemic countries, hinders vaccine development.
The example of Newcastle Disease in poultry highlights this issue.
Rapid mutations and variations in the virus make it difficult to develop effective vaccines, limiting the market potential.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Competition Analysis:

Bayer Healthcare
Vétoquinol S.A
Boehringer Ingelheim
Ceva Santé Animale
Eli Lilly and Company
Heska Corp.
Merck Animal Health
Sanofi
Virbac
Pfizer

Companion Animal Vaccines Market Segmentation

By Product Type:

Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines

By Distribution Channel:

Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Retail Pharmacies

By Species Types:

Canine
Avian
Feline

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Global Radial Compression Devices Market Set for Remarkable Growth, Expected to Reach USD 599.9 Million by 2033

The global radial compression devices market is set to experience impressive growth over the next decade, with market size projected to rise from US$ 255.5 million in 2023 to an estimated US$ 599.9 million by 2033, according to recent market projections. This surge is fueled by a Compound Annual Growth Rate (CAGR) of 8.9%, driven by advancements in interventional cardiology and the growing global burden of cardiovascular diseases (CVD).

Increasing Cardiovascular Disease Burden

Cardiovascular diseases remain the leading cause of mortality worldwide. Despite medical advancements, CVD rates continue to rise, especially in regions outside of high-income countries. Notably, in several high-income regions where CVD had been declining, a reversal of this trend has been observed. According to the American Heart Association, by 2035, more than 130 million adults in the United States are expected to suffer from some form of cardiovascular disease, underscoring the urgent need for improved diagnostic and interventional tools.

Growth Driven by Advances in Radial Artery Access

Radial artery access has become a key technique in modern interventional cardiology for cardiovascular diagnosis and intervention. Its minimally invasive nature offers several benefits, including reduced bleeding complications and faster patient recovery times. The increasing adoption of this technique is directly contributing to the rise in demand for radial compression devices, which are essential in maintaining hemostasis following these procedures.

Investments in Training and Technology

Efforts to expand the use of radial artery compression devices have been bolstered by independent cath labs investing in training for healthcare professionals. Notably, in 2009, the Jesse Brown VA Medical Center in Chicago took the initiative to train staff outside of the cath lab on the usage of these devices, ensuring a wider pool of trained personnel capable of performing these procedures safely.

Moreover, companies operating in this sector are focusing on producing enhanced radial compression devices that offer improved hemostasis while minimizing risks to local nerve structures. These design improvements are expected to drive further adoption and market growth.

Technological Advancements and Future Outlook

The increasing prevalence of cardiovascular disease, particularly among adult populations in industrialized nations, is driving demand for innovative solutions. Interventional cardiologists and radiologists stand to benefit from continuous technological advancements introduced by key players in the healthcare sector. Improved material design and the development of more efficient compression devices are expected to accelerate sales in the coming years.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Key Takeaways from Market Study:

Band/strap-based devices had the highest market share of 79.8% in 2021, expanding at a 9.6% CAGR during the forecast period. Band/Strap based radial compression devices are primarily driven by factors such as shorter hospital stays and lower surgical costs.
Disposable devices accounted for 92.9% of the market in 2021 and expanding at an impressive rate of 9.0%. Disposable radial compression devices are highly adopted due to its cost effectiveness and reduces the incidence of radial artery occlusion.
S. will lead the global market and contribute a revenue share of USD 224.6 Million by 2033. Incorporation of advanced technology and leading industry players in the marketplaces are the major factors behind their dominance.
K. witnessed a growth of USD 15.9 Million over last decade and a CAGR of 9.4%. The industry is expanding as a result of increased consumer awareness. Furthermore, government initiatives, an ageing population, and industry leaders all contribute to market growth.
China will emerge as the most lucrative region among all growing at a CAGR of 10.0%. Rapid socioeconomic advancement has had a significant impact on Chinese culture. The risk of cardiovascular disorders in the country has increased as a result of lifestyle changes, urbanisation, and an ageing population.

“Increasing use of radial compression devices in percutaneous coronary intervention procedures (PCI), due to rising cardiovascular disorders to drive the demand of radial compression over the Decade,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.

Product launching is the key strategy adopted by the manufacturers:

Companies in the Radial Compression Devices Industry are actively attempting to strengthen their positions through new product launches and approvals by both established and emerging market players. The product launch and acquisition speed up the manufacturer’s strategy to capitalise on market share and capture a sizable market share. Among the most recent examples are:

Merit Medical launched PreludeSYNC EVO, a radial compression device, in the United States in August 2019. This sterile, single-use device is used to aid in the Hemostasis of the arterial percutaneous access site following catheterization procedures.
Cordis launched the RADIAL 360 portfolio in the United States in May 2019. With this launch, the company provides a full range of products to aid in the transradial approach (TRA) for interventional cardiology.
In 2018, TZ Medical Inc. received FDA approval for its Adjustable Radial Cuff (ARC) Hemostasis Devices in the United States.

Some of the leading companies operating in the Radial Compression Devices Industry are:

Terumo Corporation
Merit Medical Inc.
Abbott Laboratories
Vascular Solutions
ConMed B.V.
Cardinal Health
Beijing Demax Medical Technology
Teleflex Incorporated
Forge Medical Inc.
TZ Medical Inc
Semler Technologies Inc
Advanced Vascular Dynamics
MedPlus, Inc.
Lepu Medical

Radial Compression Devices Industry by Category:

Product Type:

Band/Strap based radial compression devices
Knob-based radial compression devices
Plate-based radial compression devices

Application:

Diagnostic intervention
Surgical intervention

End User:

Hospitals
Independent Catheterization Labs
Ambulatory Surgery Centers
Specialized Centers

By Usage:

Disposable
Reusable

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Global Auto-Injectors Market Set for Remarkable Growth, Projected to Reach USD 67,200.1 million by 2033

The global auto-injectors market is on a significant growth trajectory, with market share expected to reach a robust valuation of USD 30,578.2 million in 2023. This figure represents a strong presence in the healthcare industry, but it’s the projected growth over the next decade that is truly captivating industry experts. By 2033, the market is anticipated to surge to an impressive USD 67,200.1 million, marking a compound annual growth rate (CAGR) of 8.2% from 2023 to 2033.

Auto-injectors, which are gaining prominence for their ease of use and efficacy in administering life-saving medications, are becoming indispensable in both clinical and emergency settings. These devices are particularly noted for delivering biologics and critical drugs, ensuring rapid response and improved patient outcomes. From 2018 to 2022, the market exhibited an even higher growth rate, with a CAGR of 11.6%, reflecting the rapid pace at which auto-injectors were adopted globally.

Adoption Surge Fueled by Convenience and Innovation

Auto-injectors have witnessed widespread adoption, particularly due to their ability to simplify drug administration for patients. Devices like EpiPen, Anapen, Jext, and Auvi-Q are now essential for individuals managing severe allergic reactions, providing swift, precise responses during anaphylactic emergencies. This growing reliance on auto-injectors has prompted extensive user training programs, ensuring that patients and caregivers are equipped to use these devices effectively during critical moments.

However, with increased adoption comes the need for heightened awareness. Consumers must be informed about potential side effects and seek appropriate insurance coverage to mitigate the cost variations among different devices. Additionally, autoinjector safety regulations remain paramount, with regulatory bodies closely monitoring safety standards and compliance. In the rare event of device-related issues, autoinjector recalls can occur, pushing users to explore alternative options.

Evolving Market Dynamics and Consumer Preferences

The auto-injector market has also seen significant developments in terms of product accessibility and consumer engagement. With many users actively searching for places to purchase devices or refill prescriptions online, the demand for streamlined, user-friendly platforms is rising. Consumers are not only seeking devices but are also researching and comparing various options, looking into manufacturers’ reviews, and staying updated on advancements in auto-injector research and development.

Meanwhile, clinical trials continue to play a crucial role in ensuring the safety and efficacy of these devices, further influencing regulatory approvals and market adoption.

The Future of Auto-Injectors: Trusted, Accessible, and Life-Saving

As the global auto-injector market grows, the focus remains on patient safety, accessibility, and continuous innovation. With a projected market size of USD 67,200.1 million by 2033, the future looks promising for the auto-injector industry, offering life-saving solutions that cater to the growing demand for effective and efficient drug delivery systems.

The increasing reliance on these devices, coupled with advancements in auto-injector technology, underscores their pivotal role in healthcare, setting the stage for continued growth and innovation in the years to come.

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Key Takeaways from the Auto-Injectors Market:

Prefilled auto-injectors dominate the market, commanding an impressive share of 86.30% in 2023.
The anaphylaxis indication Segment exhibits remarkable strength, capturing an overwhelming share of 88.7% in 2023.
The United States auto-injectors market boasts a substantial share of 29.10% in 2023.
Germany established a notable market share of 8.80% in 2023.
Japan claims a respectable market share of 1.60% in 2023.
Australia secures a significant market share of 5.60% in 2023.
China showcases its market prowess with a substantial share of 8.00% in 2023.
India also feels its impact with a substantial market share of 8.30% in 2023.

Key Players in the Auto-Injectors Market Striving for Better Revenue Prospects:

The auto-injectors industry boasts a highly competitive landscape with several prominent players vying for market share. Some notable participants include Becton, Dickinson, Company, Sanofi, Pfizer, Inc., Mylan N.V., and Novartis AG. These companies have established their dominance through innovative product offerings and strategic partnerships. Moreover, their extensive global presence enables them to cater to a wide range of therapeutic areas and patient populations.

Another key trend in the competitive landscape is the formation of strategic collaborations between pharmaceutical companies and auto-injector manufacturers. This collaboration results in co-branded devices for specific medications, ensuring precise and user-friendly drug delivery.

This approach has created a win-win situation, with pharmaceutical companies gaining a competitive edge by offering differentiated delivery solutions and auto-injector manufacturers benefiting from increased product demand. As the industry continues to evolve, these partnerships are expected to shape the competitive landscape further, driving innovation and expanding market reach.

Recent Developments in the Market:

Stevanato Group Signed an Exclusive Agreement for Aidaptus Auto-Injector: In May 2022, Stevanato Group signed an exclusive agreement with Owen Mumford Ltd. for its Aidaptus auto-injector. The Aidaptus auto-injector is designed for the self-administration of injectable drugs.
Antares Pharma Signed an Agreement for XYOSTED in the UAE and Saudi Arabia: In May 2023, Antares Pharma signed an agreement with Lunatus Global Medical Supplies for the distribution of XYOSTED, an autoinjector for the treatment of growth hormone deficiency, in the UAE and Saudi Arabia.
SHL Medical Acquires Weibel CDS: In May 2023, SHL Medical acquired Weibel CDS, a Swiss company that develops and manufactures autoinjectors. The acquisition may strengthen SHL Medical’s position in the autoinjector market.
Eli Lilly Invests in New Manufacturing Facility for Autoinjectors: In May 2023, Eli Lilly announced an investment of USD 470 million in a new manufacturing facility for autoinjectors in Durham, North Carolina. The new facility is expected to be operational in 2025.
Ypsomed Launched a New Autoinjector Platform for Liquid Pharmaceuticals: In October 2022, Ypsomed launched a new autoinjector platform for liquid pharmaceuticals with capacities between 1.5 mL and 5.5 mL. The new platform is designed to be easier and more comfortable for patients.

Key Companies in the Market:

Becton, Dickinson, and Company
Sanofi
Pfizer, Inc
Mylan N.V.
Novartis AG
Bayer AG
Janssen Global Services, LLC
Antares Pharma, Inc.
Amgen Inc
Eli Lilly and Company
Teva Pharmaceutical
Merck KgaA
GlaxoSmithKline plc
Ypsomed

Key Segments:

By Product:

Prefilled Auto-Injectors
Fillable Auto-Injectors

By Indication:

Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Surgical Stapling Device Market Set to Reach USD 5,930.60 Million by 2033, Driven by Technological Advancements and Growing Demand for Minimally Invasive Procedures

The global surgical stapling device market is poised for remarkable growth, with projections showing an increase from USD 3,977.40 million in 2023 to USD 5,930.60 million by 2033. This represents a compound annual growth rate (CAGR) of 4.10% over the forecast period, according to the latest market research report.

The anticipated surge in market value is fueled by the rising adoption of surgical stapling devices across a wide range of medical procedures. These devices are proving indispensable in laparoscopic, bariatric, and endoscopic surgeries, which are vital for managing chronic conditions such as obesity, sports-related injuries, and arthritis.

A spokesperson from Future Market Insights (FMI) commented, “The global market for surgical stapling devices is experiencing notable growth due to advancements in surgical techniques and increasing prevalence of chronic diseases. These devices play a pivotal role in ensuring precise and efficient wound closure, thereby enhancing patient outcomes and reducing recovery times.”

Key Drivers of Growth:

Technological Innovation: The report highlights the significant impact of technological advancements on the efficacy and safety of surgical stapling procedures. These innovations are improving the precision, speed, and overall success rates of surgeries.
Chronic Disease Prevalence: As chronic conditions like obesity and arthritis become more common, the demand for minimally invasive procedures, including those requiring surgical stapling devices, continues to rise.
Favorable Reimbursement Policies: Improved healthcare infrastructure and supportive reimbursement policies across various regions are expected to further drive the adoption of surgical stapling devices.

With the market poised for substantial growth, the future of surgical stapling devices will likely be shaped by ongoing innovations in medical technology and an increased focus on minimally invasive surgeries.

Key Takeaways:

In 2022, the surgical stapling devices market was valued at USD 3,827.50 Million.
Based on product type, the manual segment is expected to account for a share of 87.7% in 2023.
Based on usage, disposable segments account for a market share of 4%
Global surgical stapling devices demand in China is predicted to account for a CAGR of 5.3% through 2033.
Bags in the United States is expected to account for a CAGR of 1.8% between 2023 and 2033.
Germany is projected to expand by a value CAGR of 2.5% between 2023 and 2033.
By 2033, the surgical stapling devices market in India is anticipated to record a CAGR of 6.2% during the forecast period.

“The high volume of surgical procedures performed and growing aging population, is a major factor accelerating the market growth.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Boosted Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Competitive Landscape:

The overall market is highly fragmented, with several competitors in the surgical stapling devices production sphere. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

Medtronic in December 2020, introduced EEA™ Circular Stapler, which has the Tri-Staple™ Technology. It is a first 3-row Circular Stapler having variations in height of staples. The Tri-Staple™ Technology helps reduce the stress on the tissue and consists of a sloped cartridge face.
Intuitive Surgical is known for its da Vinci Surgical System, which includes robotic surgical staplers for minimally invasive procedures.
Braun Melsungen AG is a global medical device and pharmaceutical company that manufactures surgical stapling devices for various surgical applications.
Dextera Surgical focuses on the development of innovative stapling solutions for minimally invasive surgical procedures.

Surgical Stapling Devices Market Segmentation:

By Product:

Powered Surgical Stapling Device
Manual Surgical Stapling Device

By Usage:

Disposable Surgical Stapling Device
Reusable Surgical Stapling Device

By Stapling Type:

Straight
Curved
Circular

By Indication:

Skin
Digestive Tract
Blood Vessels
Hernia
Lung
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Sales of Liquid Smoke Market to Reach USD 245 Million by 2033, Driven by Rising Demand for Smoky Flavors in Food Products

According to Future Market Insights, the global liquid smoke market is billowing with opportunity, projected to reach a savory valuation of USD 245 million by 2033. This industry offers a flavorful investment opportunity, catering to the growing consumer demand for convenient, healthy, and flavorful food options. Liquid smoke, a water-soluble condensate of condensed wood smoke, adds a smoky taste to various food products without the hassle of traditional smoking methods.

Demand for Liquid Smoke on the Rise

Consumers are increasingly seeking out convenient and flavorful food options, driving the demand for liquid smoke:

Convenience Reigns Supreme: Busy lifestyles are fueling the demand for convenient and easy-to-use ingredients. Liquid smoke allows for quick and effortless incorporation of smoky flavors into various dishes.
Flavor First: Liquid smoke offers a delicious and rich smoky taste, enhancing the palatability of different food products. It’s a popular choice for those seeking bolder flavors without the commitment of traditional smoking.
Healthier Alternative: Liquid smoke is perceived as a healthier alternative to traditional smoking methods, as the carcinogenic elements are filtered out during processing.

Growing Factors Fueling Market Expansion

Beyond core consumer demand, several key factors are creating a promising investment landscape in the liquid smoke market:

Sustainability Matters: Liquid smoke is a more sustainable option compared to traditional smoking methods. It reduces wood consumption and eliminates the harmful pollutants associated with open fires.
E-commerce Boom: The growing popularity of online grocery shopping is providing a significant boost to the liquid smoke market. Consumers now have easy access to a wider variety of liquid smoke products from the comfort of their homes.
Global Palate Craving Smoke: The international market for liquid smoke is experiencing significant growth, particularly in regions like China with a rising middle class and increasing disposable income.
Product Innovation: Manufacturers are constantly innovating and developing new liquid smoke flavors and applications, catering to diverse consumer preferences.

Key Takeaways from the Report:

Based on application, meat and seafood segment will continue to dominate the global liquid smoke market during the forecast period.
By distribution channel, online stores segment will grow at a significant pace over the next ten years.
The United Kingdom liquid smoke market size is projected to reach US$ 13.0 million by 2033.
The USA liquid smoke market is expected to expand at a CAGR of 6.9 % during the projection period.
Liquid smoke demand in Japan is poised to surge at 9.4% CAGR between 2023 and 2033.

Who is Winning?

Leading manufacturers of liquid smoke include Azelis Holdings S.A., B&G Foods, Inc., International Flavors & Fragrances, Inc., McCormick & Company, Inc., Kerry Group PLC, Colgin, Inc., MSK Ingredients Limited, PS Seasoning, Baumer Foods, Aminola, Sacchetto SpA, and Others

Secure Your Copy Now: Gain full access to the Liquid Smoke Industry report, including Market Forecast, Company Share Analysis, Competitive Intelligence, DROT Analysis, Market Dynamics, Challenges, and Strategic Growth Initiatives.

Liquid Smoke Industry by Category

By Smoke Type:

Hickory
Mesquite
Applewood
Others

By Application:

Bakeries
Beverages
Dairy
Meat and Sea Food
Pet Food
Others

By Distribution Channel:

Supermarkets
Departmental Store
Modern Trade
Food Chain Services
Online Stores
Food and Liquid Store
Others

By Region, Liquid Smoke Market is Segmented as:

North America
Latin America
Europe
Middle East and Africa
East Asia
South Asia
Oceania

About Future Market Insights (FMI)

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Wheat Protein Market Worth USD 5.7 Billion by 2033, Shows 5.3% CAGR Growth | FMI

The wheat protein market is expected to be worth US$ 3.4 billion in 2023, with total Wheat Protein revenue expected to grow at a 5.3% CAGR from 2023 to 2033, reaching around US$ 5.7 billion.

The wheat protein market was valued at US$ 3.3 billion in 2022 and is estimated to increase at a 4.7% CAGR during the forecast period. Absolute dollar growth in the global market is $2.3 billion. Rising demand for wheat protein from various end-use sectors, combined with rising consumer desire for meat-free diets, is a primary factor driving the global wheat protein market.

Wheat protein market growth is predicted to be driven by increased plant-based diet adoption as well as a rise in the number of people adopting vegan diets in developing economies. Furthermore, a growing senior population, rising income levels, and increased urbanization are projected to drive product demand.

Get The Sample Copy Of Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-6395

Wheat protein has outstanding possibilities for a wide range of sectors due to several advantages. Bakery items, flour milling, meat replacer, pasta, aqua-feed, breakfast cereal, milk replacer, and pet food are just a few of the applications. The flour miller, also known as the baker’s adjustment, is the most basic and extensively utilized application of wheat protein. As a result, market expansion is expected to be fueled by such a diverse variety of applications for various end-use industries over the forecast period.

Although whey protein isolates are more filtered and processed than whey protein concentrates to successfully eliminate more lactose, those with even a little lactose allergy should avoid such products. Lactose intolerance occurs when the body is unable to digest lactose, a natural sugar found in dairy products such as milk. Plant-based alternatives such as wheat protein are the best option for customers who wish to increase their protein intake for health or training objectives, which may contribute to market growth.

Key Points

Wheat Protein Market is expected to develop at a 5.3% CAGR from 2023 to 2033.
The Wheat Protein Market was dominated by North America.
By 2033, the Wheat Protein Market is estimated to exceed US$ 5.7 billion.
Wheat gluten dominated the product group from 2023 to 2033, accounting for the highest sales share of 3.2%.
China and India are two of the leading producers.

Get Full Access of this Report@ https://www.futuremarketinsights.com/checkout/6395

Recent Developments

In September 2020, ADM introduced Prolite MeatTEX textured wheat protein and Prolite MeatXT non-textured wheat protein, both of which add flesh-like texture to meat and seafood substitute products. They feature a clean taste, a white color basis, and faster water absorption and hydration rates.
MGP Ingredients will debut the ProTerra line of textured proteins in April 2020. ProTerra is ideal for use as an extension or partial substitute for meat in vegetarian/vegan applications, as well as in blended products.
Agrana opened a new wheat starch processing plant in Austria in November 2019. Agrana will be able to increase its wheat starch production capacity thanks to the new plant. Agrana’s enlarged wheat starch mill can process about 650,000 tonnes of wheat per year to create 50,000 tonnes of wheat gluten.
In July 2019, Cargill invested US$ 200 million in the production of wheat-based ingredients at its Krefeld, Germany, manufacturing facility. This investment will enable the company to diversify its wheat protein portfolio and address the growing market demand for protein-rich foods.

Wheat Protein Market Key Segment

By Product:

Wheat Gluten
Wheat Protein Isolate
Hydrolysed Wheat Protein
Textured Wheat Protein

By Form:

Dry
Liquid

By Application:

Animal Feed
Bakery & Confectionary
Nutrition Supplements
Dairy Products
Cosmetics and Personal Care
Other Applications

By Region:

North America
Latin America
Europe
Asia Pacific Excluding Japan
Japan
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Food Botanicals Market to Reach USD 272.8 Billion by 2034, Driven by Growing Demand for Plant-Based Diets Among Vegetarian and Vegan Consumers

The worldwide food botanicals market size is expected to be USD 219.4 billion in 2024. The sector’s progress is expected to happen at a CAGR of 2.2% from 2024 to 2034. By the end of the forecast period, the food botanicals industry value is slated to hit USD 272.8 billion.

Demand for botanicals in food is accelerating due to the rising number of vegetarian and vegan consumers. While adopting plant-based diets, these consumers want to ensure that health is not skimped on. Thus, there is greater demand for botanicals in food.

Food botanicals’ therapeutic properties, as well as consumer demand for functional foods, have propelled the market for food botanicals to new heights. However, a lack of dosing directions, potential toxicity hazards, and the adoption of contemporary treatments may stymie the market’s growth.

Nonetheless, the growing preference for organic goods, as well as technical improvements in the area, present significant growth prospects for the food botanicals market over the forecast period.

Within the global market for food botanicals, the appeal of food products created from plant materials has been at the forefront of growth. Furthermore, the demand for herbs and spices has been increasing at an exponential rate, contributing to the overall expansion of the global food botanicals market.

Botanicals are widely used in food and dietary supplements because they have a variety of qualities that aid in the improvement and maintenance of health. Botanicals are available in a variety of forms, including dried or fresh items, tablets, liquid, capsules, and powder.

Key Takeaways from the Market Study

The food botanicals market is expected to expand at CAGRs of 8% and 9.3% in Latin America and the Middle East & Africa, respectively, through 2032.
Market share of South Asia and Oceania is 18.3% and 9.6%, respectively, in 2022, as the plant-based protein is in great demand amongst vegetarians, and this factor is expected to create lucrative opportunities within the global market for food botanicals.
The numerous varieties of food botanicals available on the market, together with improvements in the global food sector, will drive the worldwide food botanicals market to record high revenues.
Among the source segment of the food botanicals market, the leading category is the plant, which represents 32.4% market share in 2022, and is anticipated to grow up to 35.8%, with a CAGR of 5.7%.

“The availability of well-known botanicals as dietary supplements is driving market expansion globally. Food botanicals are also growing in popularity in Europe and North America as a result of increased research and development.” says a Future Market Insights analyst.

Competitive Landscape

Manufacturers are focusing on the opportunity as the crucial driver driving the worldwide food botanicals market is the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and arthritis, as well as the long-term use of modern pharmaceuticals, which leads to additional negative effects.

In addition, the growing use of botanicals in the cosmetics industry, particularly in hair and skincare products, is expected to propel the sales of the global food botanicals market benefitting the manufacturers.

Market Taxonomy: Food Botanicals Market

The report offers a detailed analysis of all the market segments in the report, along with a detailed description of all the stages through which food botanicals pass before reaching end-users. These stages include raw material suppliers, manufacturers, and end-users. The report also comprises key metrics such as year-on-year growth, revenue, market size, absolute dollar opportunity, CAGR, basis point share, and other key numbers.

Region :

North America
Latin America
Europe
Japan
APEJ
MEA

Source :

Plants
Algae
Fungi or Lichens

Form :

Dried Plants and Leaves
Oelioresins
Essential Oils
Other Form

Application :

Beverages
Confectionery
Supplements
Flavor Enhancers
Other Applications

End Users :

Commercial
Residential

About Future Market Insights (FMI)

Fortified Dairy Products Market to Reach USD 48.28 Billion by 2034, Driven by Rising Nutrient Deficiencies and Government Support for Food Fortification

The global fortified dairy products sales are valued at USD 28,400 million by 2024 and are estimated to reach a value of USD 48,280 million by 2034, with the global market reflecting a CAGR of 5.4% over the assessment period 2024 to 2034

Globally rising rates of nutrient deficiencies are driving individuals to look for foods products with added health benefits. In an effort to fight hunger and deficiencies, governments and health groups are also supporting food fortification, which is driving up demand for fortified dairy products.

Increased customer interest is anticipated as a result of the ease with which probiotics, vitamins, minerals, and other nutrients can now be added to dairy products without sacrificing flavor or quality because to technological developments in food fortification processes.

It is expected that North America and Europe will continue to hold leading positions in the region because of their well-established dairy sectors and high levels of consumer health concern. There is a particularly high demand for fortified milk, yogurt, cheese, and baby formula in these areas.

The Asia-Pacific area, on the other hand, is predicted to increase at the fast rate. With their sizable populations and high incidence of nutritional inadequacies, countries like China and India offer substantial prospects for expansion. Furthermore, emerging countries in Latin America and the Middle East and Africa are anticipated to rise rapidly as a result of bettering economic conditions and rising consumer awareness.

Key Takeaways from Market Study

North America lead the Fortified Dairy Products Market, with a 45 percent share.
The worldwide Fortified Dairy Products market is predicted to grow rapidly in Asia Pacific excluding Japan (APEJ) due to increased demand for healthier foods..
During the forecast period of 2022-2032, the flavoured milk category is predicted to develop at the fastest rate in terms of value, with a CAGR of x.x %.
During the forecast period of 2022-2032, the mineral segment is predicted to develop at the fastest rate in terms of value, with a CAGR of 7.3 %.
Market players are experimenting with new ways on increasing production capacity and also doing research and innovation to create products.

“The Fortified Dairy Products Market is being propelled by increasing technological innovation, which promotes the production of dairy products that are favourable to one’s health.”, –says a lead analyst at Future Market Insights.

Competitive Landscape

Fortified Dairy Products have a strongly competitive global market. The Fortified Dairy Products Market is going forward as producers focus on developing a variety of baked items that will enhance customer demand.

Some of the leading companies offering Fortified Dairy Products are Arla Foods UK Plc, Nestlé S.A., BASF SE, General Mills, Inc., Danone, Dean Foods Company, Bright Dairy & Food Co., Ltd., China Modern Dairy Holdings Ltd, GCMMF Ltd., and Fonterra Group Cooperative Limited.

To Gain More Insights about this Research, Visit! https://www.futuremarketinsights.com/reports/fortified-dairy-products-market

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the Fortified Dairy Products presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the Fortified Dairy Products based on Micronutrients (Minerals, Vitamins, Other Fortifying Nutrients),Type (Flavored Milk, Milk , Dairy Based Yogurt , Milk Powder, Cheese, Other Products), Sales Channel (Drug Stores Departmental Stores, Convenience Stores, Modern Trade, Online Stores, Other Sales Channel).

About Future Market Insights (FMI)

Banana Flakes Market to Hit USD 810 Million by 2032, Boosted by Rising Global Demand for Organic and Healthier Food Options

According to a recent report by Future Market Insights, a market research and competitive intelligence provider, sales of Banana Flakes are estimated to reach a value of USD 810 million by 2032, surging at 4.6% CAGR through the decade.

The growing demand for organic goods in both developed and developing countries has a big influence on the global banana flakes market. As people become even more increasingly health – conscious across the world, there is a growing desire for healthier foods.

Organic food consumption is becoming more popular throughout the world, with people becoming more interested in organic production practices. Growing market for gluten-free, organic, and nutritious products is anticipated to raise the demand for banana flakes over the next decade.

The growth of fast service local restaurants outlets in emerging countries including the Middle East and Africa, as well as Asia and the Pacific, has resulted in a favourable shift in demand for banana flakes as a healthy fast food alternative.

This trend is expected to continue and extend throughout developed regions in the coming years. Despite the fact that conventional is the more popular source in terms of units eaten, the organic category is projected to grow at the rapid pace in terms of revenue throughout the forecast period.

Key Takeaways from Market Study

Banana flake consumption in India is predicted to expand at an annual pace of over 8%.
With a growth expected to surpass 6%, Germany is one of the most important countries in the European Snack Pellets market.
During the forecast period of 2022-2032, the organic category is predicted to develop at the fastest rate in terms of value, with a CAGR of 6.5 percent.
As banana flakes are gluten-free, their popularity is predicted to grow as a result of their health benefits.
Market players are experimenting with new ways on increasing production capacity and also doing research and innovation to create products.

“ The growing focus on the consumption of organic food products in developed regions such as Europe and North America is likely to open lucrative opportunity for market players in the long run”, –says a lead analyst at Future Market Insights.

Competitive Landscape

Banana flakes have a strongly competitive global market. To stay ahead of the game and outperform their competitors, businesses are using innovative methods such as expanding their worldwide client base and utilising various advertising approaches.

They’re focusing on increasing production capacity and also doing research and innovation to create products that highlight the nutritional advantages of banana flakes.

Some of the leading companies offering Snack Pellets are Orkla Group, Raeler Fruchtchips GmbH, Om Foods Inc, Van Duren Farms, Johs. Thoms GmbH & Co. KG, Tradal Brazil, Z Natural Foods, Symrise, Seawind International LLC, VINJ-Food,Dermasal., Nutritional Designs, Inc., Futurcorp S.A., Cosmo Foods, Agro America, and Grupo Industrial Michel.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the banana flakes presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the banana flakes based on by Application (Household, Food & Beverage Industry), Source (Organic, Conventional), Sales Channel (Direct Sales, Indirect Sales), and across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, APEJ, and MEA).

Secure Your Copy Now: Gain full access to the banana flakes Industry report, including Market Forecast, Company Share Analysis, Competitive Intelligence, DROT Analysis, Market Dynamics, Challenges, and Strategic Growth Initiatives.

About Future Market Insights (FMI)